For Health Care Providers (HCPs)

VeraCept Clinical Data

CAUTION: New Drug – Limited by Federal Law to Investigational Use

ContraMed is actively recruiting Phase 2 Clinical Study participants in a number of U.S. cities.

Clinical Study Title:
Evaluation of ContraMed VeraCept Intrauterine Copper Contraceptive for Long Acting Reversible Contraception Identifier:

Learn more about the VeraCept Clinical Trial

Additional Clinical Information